Mapi Pharma ^{For Profit}

Mapi Pharma is a clinical stage pharmaceutical company located in Ness Ziona, Israel. They are focused on developing long acting depot injectable drugs, including life cycle management (LCM) products, complex active pharmaceutical ingredients (APIs) and formulations. Their lead product is Glatiramer Acetate (GA, Copaxone®) Depot, a once-monthly IM injection of 40mg GA for the treatment of multiple sclerosis. They are also engaged in the development of Pregabalin ER for the treatment of neuropathic pain and epilepsy, Paliperidone Palmitate and Buspirone ER for the treatment of schizophrenia and other long acting Depot injectable treatments. They have fully integrated GMP manufacturing facilities and a pipeline of multiple late stage products. Contact info: Weizmann Science Park16 Einstein St.Ness Ziona, Israel 7403620+972-73-7121213+972-8-9100154info@mapi-pharma.com